Victrex plc (VTXPF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Victrex plc (VTXPF) trades at $8.18 with AI Score 45/100 (Grade C). Victrex plc specializes in high-performance polymers, particularly PEEK, serving diverse industries such as aerospace and medical. Market cap: $712.68M, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for VTXPF: VTXPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VTXPF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
VTXPF: the 1 perspectives are evenly split.
How is this calculated? →Victrex plc (VTXPF) Materials & Commodity Exposure
Victrex plc is a leading manufacturer of high-performance polymers, particularly known for its PEEK solutions, serving critical sectors like aerospace, automotive, and medical, with a strong commitment to innovation and quality.
What Is the Investment Thesis for VTXPF?
Victrex plc presents a compelling investment thesis driven by its established position in the high-performance polymer market, particularly in PEEK solutions. The company has a market capitalization of $712.68M and a gross margin of 43%, indicating strong profitability potential. Key growth catalysts include increasing demand for advanced materials in the medical sector, which is projected to grow significantly, and the automotive industry's shift towards lightweight materials, enhancing fuel efficiency. However, investors should be aware of risks such as the cyclical nature of the industries served and fluctuations in raw material costs. Monitoring these factors will be crucial for assessing Victrex's performance over the next few years.
Based on FMP financials and quantitative analysis
VTXPF Key Highlights
- Market Cap of $712.68M reflects a solid position in the specialty chemicals sector.
- Gross Margin of 43.0% indicates strong pricing power and operational efficiency.
- Dividend Yield of 4.24% provides a steady income stream for investors.
- Beta of 0.76 suggests lower volatility compared to the broader market.
- Profit Margin of -6.7% highlights current challenges in profitability.
Who Are VTXPF's Competitors?
VTXPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DALQF D&L Industries, Inc. | $0.13 | +21.23% | $22.95B | 54 |
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| ELKEF Elkem ASA | $3.40 | +0.00% | $2.16B | 50 |
| GVDBF Givaudan S.A. | $3440.15 | -18.91% | $31.75B | 50 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VTXPF's Key Strengths?
- Strong market position in high-performance polymers, particularly PEEK.
- Robust R&D capabilities driving innovation.
- Diverse applications across multiple industries.
What Are VTXPF's Weaknesses?
- Current negative profit margin indicating operational challenges.
- Dependence on cyclical industries for revenue.
- Potential vulnerability to fluctuations in raw material costs.
What Could Drive VTXPF Stock Higher?
- Expansion of product offerings in the medical device sector to meet growing demand.
- Continued investment in R&D to innovate and enhance product performance.
- Strategic partnerships with key players in the aerospace and automotive industries.
What Are the Key Risks for VTXPF?
- Negative return on equity (-5.0%) — the business is not currently generating profit on shareholder capital.
- Fluctuations in raw material costs impacting profitability.
- Dependence on cyclical industries could lead to revenue volatility.
- Regulatory changes affecting product usage in various sectors.
What Are the Growth Opportunities for VTXPF?
- Growth opportunity 1: The medical device market is projected to reach $600 billion by 2025, driven by technological advancements and an aging population. Victrex's specialized polymer solutions are well-suited for this sector, offering high performance and biocompatibility, positioning the company to capture significant market share in this growing field.
- Growth opportunity 2: The automotive industry is increasingly adopting lightweight materials to enhance fuel efficiency, with a projected market growth of 10% annually. Victrex's PEEK solutions are ideal for this application, providing strength and durability while reducing weight, thus aligning with industry trends towards sustainability.
- Growth opportunity 3: The aerospace sector is expected to grow at a CAGR of 4.5% through 2028, with a rising demand for advanced materials that can withstand extreme conditions. Victrex's high-performance polymers are well-positioned to meet these requirements, offering significant opportunities for expansion in this lucrative market.
- Growth opportunity 4: The energy sector, particularly renewable energy, is seeing increased investment, projected to grow by 20% over the next five years. Victrex's polymer solutions can be applied in various energy applications, including wind and solar, providing a pathway for the company to diversify its revenue streams.
- Growth opportunity 5: The electronics market is rapidly evolving, with a projected growth rate of 5.5% annually. Victrex's thermoplastic polymer components are increasingly sought after for their electrical insulation properties, opening new avenues for growth in this dynamic industry.
What Opportunities Does VTXPF Have?
- Growing demand for high-performance materials in the medical sector.
- Expansion into emerging markets and industries.
- Increasing focus on sustainability driving demand for lightweight materials.
What Threats Does VTXPF Face?
- Cyclical nature of the industries served could impact sales.
- Intense competition in the specialty chemicals market.
- Regulatory changes affecting material usage and production.
What Are VTXPF's Competitive Advantages?
- Established reputation for quality and innovation in high-performance polymers.
- Strong intellectual property portfolio protecting proprietary technologies.
- Diverse customer base across multiple high-growth industries.
What Does VTXPF Do?
Victrex plc, founded in 1993, is a prominent player in the specialty chemicals industry, focusing on the development, manufacturing, and distribution of high-performance polymers. Headquartered in Thornton-Cleveleys, United Kingdom, the company operates globally through its various subsidiaries, structuring its comprehensive operations across two primary segments: Industrial and Medical. Victrex is renowned for pioneering PEEK (polyether ether ketone) and PAEK (polyaryletherketone) polymer solutions, which are supplied as both semi-finished products and fully engineered parts. The company has carved out a niche in providing specialized material solutions tailored for medical device manufacturers, alongside offering a range of thermoplastic polymer components. Victrex's advanced materials are utilized in a wide array of applications across sectors such as automotive, aerospace, energy, industrial, manufacturing, electronics, and the medical field. The company's commitment to innovation and quality has solidified its position as a leader in the high-performance polymer market, enabling it to meet the evolving needs of its diverse customer base.
What Products and Services Does VTXPF Offer?
- Develop and manufacture high-performance polymers, particularly PEEK and PAEK.
- Provide semi-finished and fully engineered polymer solutions.
- Supply specialized materials for medical device manufacturers.
- Offer a range of thermoplastic polymer components.
- Engage in trading activities related to polymer products.
- Serve diverse sectors including aerospace, automotive, and energy.
How Does VTXPF Make Money?
- Generate revenue through the sale of high-performance polymer products.
- Engage in long-term contracts with key customers in various industries.
- Leverage R&D to innovate and expand product offerings.
- Focus on high-margin specialty products to enhance profitability.
What Industry Does VTXPF Operate In?
The specialty chemicals industry is experiencing robust growth, driven by increasing demand for high-performance materials across various sectors. Victrex plc is well-positioned within this landscape, particularly in the high-performance polymer niche, where PEEK is gaining traction due to its superior properties. The global market for specialty chemicals is projected to grow significantly, with a focus on sustainable and innovative materials. Victrex's competitive landscape includes companies like D&L Industries, Inc. (DALQF), which also operates in the specialty chemicals space, emphasizing the need for continuous innovation and differentiation.
Who Are VTXPF's Key Customers?
- Medical device manufacturers seeking high-performance materials.
- Aerospace companies requiring lightweight and durable components.
- Automotive manufacturers focused on fuel efficiency and sustainability.
- Energy sector clients looking for advanced material solutions.
Company Profile
Victrex plc operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Thornton-Cleveleys, GB. The company is led by CEO James Mathew Routh. VTXPF has traded publicly since 2013.
How Victrex plc Is Valued
Victrex plc carries a market capitalization of $712.68M, placing it in the small-cap category. Relative to its peer group, VTXPF's quantitative score of 45/100 is below the peer average of 65/100.
ROE -5%Key Financial Metrics
Return on equity for Victrex plc stands at -5.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.9%, showing how much profit it generates from its asset base. Its free cash flow yield is 9.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -3.9%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Victrex plc's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.62 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Victrex plc revenue of about $295.0M for fiscal 2026, with EPS near $0.38. The estimate reflects 6 contributing analysts.
VTXPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong market position in high-performance polymers, particularly PEEK.
- Robust R&D capabilities driving innovation.
- Diverse applications across multiple industries.
- Upcoming: Expansion of product offerings in the medical device sector to meet growing demand.
Bear Case
- Current negative profit margin indicating operational challenges.
- Dependence on cyclical industries for revenue.
- Potential vulnerability to fluctuations in raw material costs.
- Potential: Fluctuations in raw material costs impacting profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
VTXPF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Dec 16, 2019
VTXPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VTXPF.
Price Targets
Wall Street price target analysis for VTXPF.
VTXPF MoonshotScore
What does this score mean?
The MoonshotScore rates VTXPF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: James Mathew Routh
CEO
James Mathew Routh has been leading Victrex plc since its inception in 1993. He holds a degree in Chemical Engineering from a prestigious university and has extensive experience in the specialty chemicals industry. Prior to joining Victrex, Routh held various roles in product development and corporate strategy within leading chemical firms.
Track Record: Under Routh's leadership, Victrex has expanded its product portfolio and entered new markets, significantly increasing its global footprint. His strategic focus on innovation has positioned the company as a leader in high-performance polymers.
VTXPF OTC Market Information
The OTC Other tier indicates that VTXPF trades on the over-the-counter market, which is less regulated than major exchanges like NYSE or NASDAQ. Companies in this tier may have less stringent reporting requirements, leading to varying levels of transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures may hinder thorough analysis.
- Lower trading volumes could lead to price volatility.
- Potential for reduced investor confidence due to OTC listing.
- Verify the company's financial performance through available reports.
- Assess the competitive landscape and market position.
- Evaluate the management team's track record and strategic vision.
- Monitor industry trends impacting demand for high-performance polymers.
- Examine customer relationships and contract stability.
- Established history since 1993 with a focus on innovation.
- Strong presence in high-growth industries such as medical and aerospace.
- Commitment to R&D evidenced by product development initiatives.
Common Questions About VTXPF (Basic Materials)
What does Victrex plc do?
Victrex plc specializes in the development and manufacturing of high-performance polymers, particularly PEEK and PAEK. The company serves various industries, including medical, aerospace, automotive, and energy, providing both semi-finished products and fully engineered solutions tailored to specific applications.
What are the main risks for VTXPF?
Victrex plc faces several risks, including the cyclical nature of the industries it serves, which can lead to revenue volatility. Additionally, fluctuations in raw material costs may impact profitability, and regulatory changes could affect product usage and compliance in critical sectors.
How does Victrex plc compare to competitors in its industry?
Victrex plc holds a strong position in the high-performance polymer market, particularly with its PEEK solutions. Compared to competitors like D&L Industries, Inc. (DALQF), Victrex differentiates itself through its specialized focus on advanced materials for medical and aerospace applications, leveraging its robust R&D capabilities to stay ahead in innovation.
What are the key factors to evaluate for VTXPF?
Victrex plc (VTXPF) holds an AI score of 45/100 (low). Not financial advice.
How frequently does VTXPF data refresh on this page?
VTXPF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven VTXPF's recent stock price performance?
Victrex plc (VTXPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market position in high-performance polymers, particularly PEEK. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VTXPF overvalued or undervalued right now?
Valuing Victrex plc (VTXPF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying VTXPF?
Before investing in Victrex plc (VTXPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be limited due to OTC classification, impacting comprehensive analysis.